BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 31548802)

  • 1. Utility of a chemotherapy toxicity prediction tool for older patients in a community setting.
    Mariano C; Jamal R; Bains P; Hejazi S; Chao L; Wan J; Ho J
    Curr Oncol; 2019 Aug; 26(4):234-239. PubMed ID: 31548802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting chemotherapy toxicity in older adults: Comparing the predictive value of the CARG Toxicity Score with oncologists' estimates of toxicity based on clinical judgement.
    Moth EB; Kiely BE; Stefanic N; Naganathan V; Martin A; Grimison P; Stockler MR; Beale P; Blinman P
    J Geriatr Oncol; 2019 Mar; 10(2):202-209. PubMed ID: 30224184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncologists' perceptions on the usefulness of geriatric assessment measures and the CARG toxicity score when prescribing chemotherapy for older patients with cancer.
    Moth EB; Kiely BE; Stefanic N; Naganathan V; Martin A; Grimison P; Stockler MR; Beale P; Blinman P
    J Geriatr Oncol; 2019 Mar; 10(2):210-215. PubMed ID: 30503312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The predictive value of G8 and the Cancer and aging research group chemotherapy toxicity tool in treatment-related toxicity in older Chinese patients with cancer.
    Chan WL; Ma T; Cheung KL; Choi H; Wong J; Lam KO; Yuen KK; Luk MY; Kwong D
    J Geriatr Oncol; 2021 May; 12(4):557-562. PubMed ID: 33127385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the CARG tool, the VES-13, and oncologist judgment in predicting grade 3+ toxicities in men undergoing chemotherapy for metastatic prostate cancer.
    Alibhai SM; Aziz S; Manokumar T; Timilshina N; Breunis H
    J Geriatr Oncol; 2017 Jan; 8(1):31-36. PubMed ID: 27756545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The performance of three oncogeriatric screening tools - G8, optimised G8 and CARG - in predicting chemotherapy-related toxicity in older patients with cancer. A prospective clinical study.
    Kotzerke D; Moritz F; Mantovani L; Hambsch P; Hering K; Kuhnt T; Yahiaoui-Doktor M; Forstmeyer D; Lordick F; Knödler M
    J Geriatr Oncol; 2019 Nov; 10(6):937-943. PubMed ID: 31085136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective comparison of the value of CARG, G8, and VES-13 toxicity tools in predicting chemotherapy-related toxicity in older Turkish patients with cancer.
    Cavdar E; Iriagac Y; Karaboyun K; Avci O; Seber ES
    J Geriatr Oncol; 2022 Jul; 13(6):821-827. PubMed ID: 35361561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of a Geriatric Oncology Clinic on Treatment Decisions in Mexican Older Adults With Cancer.
    Verduzco-Aguirre HC; Navarrete-Reyes AP; Chavarri-Guerra Y; Ávila-Funes JA; Soto-Perez-de-Celis E
    J Am Geriatr Soc; 2019 May; 67(5):992-997. PubMed ID: 30644088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer Aging Research Group (CARG) score in older adults undergoing curative intent chemotherapy: a prospective cohort study.
    Ostwal V; Ramaswamy A; Bhargava P; Hatkhambkar T; Swami R; Rastogi S; Mandavkar S; Ghosh J; Bajpai J; Gulia S; Srinivas S; Rath S; Gupta S
    BMJ Open; 2021 Jun; 11(6):e047376. PubMed ID: 34187825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering the fitness of older patients for chemotherapy: an exploration of Comprehensive Geriatric Assessment in practice.
    McCarthy AL; Cook PS; Yates P
    Health (London); 2014 Mar; 18(2):196-212. PubMed ID: 23703221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elderly patients with advanced NSCLC: The value of geriatric evaluation and the feasibility of CGA alternatives in predicting chemotherapy toxicity.
    Almodovar T; Teixeira E; Barroso A; Soares M; Queiroga HJ; Cavaco-Silva J; Barata F
    Pulmonology; 2019; 25(1):40-50. PubMed ID: 30266308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study.
    Mohile SG; Mohamed MR; Xu H; Culakova E; Loh KP; Magnuson A; Flannery MA; Obrecht S; Gilmore N; Ramsdale E; Dunne RF; Wildes T; Plumb S; Patil A; Wells M; Lowenstein L; Janelsins M; Mustian K; Hopkins JO; Berenberg J; Anthony N; Dale W
    Lancet; 2021 Nov; 398(10314):1894-1904. PubMed ID: 34741815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting cumulative incidence of adverse events in older patients with cancer undergoing first-line palliative chemotherapy: Korean Cancer Study Group (KCSG) multicentre prospective study.
    Kim JW; Lee YG; Hwang IG; Song HS; Koh SJ; Ko YH; Shin SH; Woo IS; Hong S; Kim TY; Kim SY; Nam BH; Kim HJ; Kim HJ; Lee MA; Kwon JH; Hong YS; Bae SH; Koo DH; Kim KI; Kim JH
    Br J Cancer; 2018 May; 118(9):1169-1175. PubMed ID: 29576622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of the Index4 tool for chemotherapy toxicity prediction in cancer patients older than 70 years old.
    Lewis A; Reed M; Walde N; Voutsadakis IA
    Sci Rep; 2023 Jan; 13(1):1082. PubMed ID: 36658198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology.
    Mohile SG; Dale W; Somerfield MR; Schonberg MA; Boyd CM; Burhenn PS; Canin B; Cohen HJ; Holmes HM; Hopkins JO; Janelsins MC; Khorana AA; Klepin HD; Lichtman SM; Mustian KM; Tew WP; Hurria A
    J Clin Oncol; 2018 Aug; 36(22):2326-2347. PubMed ID: 29782209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the Cancer and Aging Research Group Predictive Model for Chemotherapy-Related Toxic Effects in a Multiethnic, Older Adult Asian Population.
    Pang A; Jiali L; Ng A; Cheng J; Wang M; Ng YS; Yao Y; Chun M; Ho F; Tey J
    JAMA Netw Open; 2022 Oct; 5(10):e2237196. PubMed ID: 36255721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study of the implementation of G8 screening tool, Cognitive screening assessment and Chemotherapy Toxicity assessment in older adults with cancer in a Tertiary University Hospital in Ireland.
    AlSendi M; Flynn CR; Khan MR; Selvadurai P; Crown J; McDermott RS; Walshe JM; Fennelly DW; Hanrahan EO; Doherty M; Higgins MJ
    Ir J Med Sci; 2024 Feb; 193(1):45-50. PubMed ID: 37450258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the Risks of Aggressive-Intent Chemotherapy Toxicity in Older Patients With Lymphoma: A Prospective Observational Pilot Study.
    Dhir V; Maganti M; Rozenberg D; Kukreti V; Kuruvilla J; Crump M; Prica A
    Clin Lymphoma Myeloma Leuk; 2022 Aug; 22(8):e792-e803. PubMed ID: 35650009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective comparison of the value of CRASH and CARG toxicity scores in predicting chemotherapy toxicity in geriatric oncology.
    Zhang J; Liao X; Feng J; Yin T; Liang Y
    Oncol Lett; 2019 Nov; 18(5):4947-4955. PubMed ID: 31612006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors and effects of toxicity experienced by older adults with cancer receiving systemic therapy in a randomized clinical trial of geriatric assessment.
    Mariano C; Brennenstuhl S; Alibhai S; Tejero I; Strohschein F; Monette J; Szumacher E; Hsu T; Puts M
    J Geriatr Oncol; 2023 Sep; 14(7):101584. PubMed ID: 37429107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.